Cargando…
Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening
BACKGROUND: Implementation of surveillance programs for at-risk populations and identification of biomarkers for early hepatocellular carcinoma (HCC) detection are a major public health goal. Recently, osteopontin (OPN) has attracted attention as a promising biomarker, with some potential advantages...
Autores principales: | Simão, Adélia, Madaleno, João, Silva, Nuno, Rodrigues, Fernando, Caseiro, Paula, Costa, José Nascimento, Carvalho, Armando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487194/ https://www.ncbi.nlm.nih.gov/pubmed/26122937 http://dx.doi.org/10.1186/s12876-015-0307-1 |
Ejemplares similares
-
Polymyositis and the Spectrum of Scleroderma Disorders
por: Cochicho, Joana, et al.
Publicado: (2015) -
Occult hepatitis C infection identified in injection drug users with direct antiviral agents therapy and spontaneous resolution of hepatitis C virus infection
por: Silva, Eliane, et al.
Publicado: (2023) -
Evaluation of Osteopontin as a Biomarker in Hepatocellular Carcinomas in Egyptian Patients with Chronic HCV Cirrhosis
por: Abdel-Hafiz, Samah Mamdouh, et al.
Publicado: (2018) -
Clinical Utility of Plasma Glypican-3 and Osteopontin as Biomarkers of Hepatocellular Carcinoma
por: Lee, Hyun Jung, et al.
Publicado: (2014) -
Clinical Significance of Plasma Osteopontin Level as a Biomarker of Hepatocellular Carcinoma
por: Salem, Mona, et al.
Publicado: (2013)